INN monograph
Neomycin / Miconazole / Betamethasone valerate
Dermatology · POM
Verified
Kenya market
Wholesale / list prices where loaded
Risk first
Contraindications
No structured CI text — verify product SmPC.
Point of care
Dosing
Adult
See SmPC / STG for indication-specific dose.
Paediatric
Weight-based — use paediatric formulary / SmPC.
Renal
Check SmPC; many renally cleared drugs need CrCl adjustment.
Hepatic
Check SmPC in significant liver disease.
Safety
Drug interactions
No structured interaction monograph text. Use the multi-drug checker and SmPC.
Safety
Adverse effects
ADR text pending — consult SmPC.
Use
Indications
Inflammation and infection of the skin particularly fungal and/or bacterial, contact eczema, atopic dermatitis, seborrheic dermatitis, mycotic eczema, microbial eczema, etc.
Pharmacology
Mode of action
Mechanism not yet curated for this INN — confirm SmPC.
ADME
Pharmacokinetics & PD
| Clinical PK/PD | Data pending. |
|---|
Kenya
Brands & prices
| Brand | Company | Pack | KES |
|---|---|---|---|
| No brands linked yet. | |||
Special populations
Pregnancy & lactation
Pregnancy
See SmPC / obstetric guidance.
Lactation
See SmPC / lactation reference.
Diet
Food & alcohol
- Topical Application Guidance For external, topical application only. Food, meal timing, and beverage intake do not affect the absorption or efficacy of Neomycin / Miconazole / Betamethasone valerate.
Trust
Sources & disclaimer
Source: MyDrugIndex clinical corpus
Decision support only — not a substitute for clinical judgment, product SmPC, or Kenya STG/EML.